Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genedx Holdings Corp 333 Ludlow Street North Tower 6th Floor Stamford CT 06902 USA

www.genedx.com Employees: 1,000 P: 888-729-1206 F: 201-421-2010

Sector:

Medical

Description:

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

Key Statistics

Overview:

Market Capitalization, $K 2,643,074
Enterprise Value, $K 2,609,774
Shares Outstanding, K 28,905
Float, K 20,349
% Float 70.40%
Short Interest, K 3,620
Short Float 12.52%
Days to Cover 5.05
Short Volume Ratio 0.62
% of Insider Shareholders 29.60%
% of Institutional Shareholders 61.72%

Financials:

Annual Sales, $ 305,450 K
Annual Net Income, $ -52,290 K
Last Quarter Sales, $ 116,740 K
Last Quarter Net Income, $ -7,640 K
EBIT, $ 9,970 K
EBITDA, $ 31,920 K

Growth:

1-Year Return 30.25%
3-Year Return 432.87%
5-Year Return -88.00%
5-Year Revenue Growth 55.71%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.49 on 10/28/25
Next Earnings Date 02/23/26 [BMO]
Earnings Per Share ttm 1.97
EPS Growth vs. Prev Qtr -2.00%
EPS Growth vs. Prev Year 1,125.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-33 on 05/04/23

WGS Ratios

Ratio
Price/Earnings ttm 48.11
Price/Earnings forward 163.41
Price/Earnings to Growth N/A
Return-on-Equity % 20.22%
Return-on-Assets % 11.89%
Profit Margin % -17.12%
Debt/Equity 0.18
Price/Sales 6.45
Price/Cash Flow 92.62
Price/Book 9.37
Book Value/Share 10.11
Interest Coverage -0.69
60-Month Beta 2.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar